Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Rishi Surana"'
Autor:
Julie N. Graff, Mark N. Stein, Rishi Surana, Luai Al Rabadi, Eric Liu, Lawrence Fong, Shawna Bailey, Emile Latour, Timothy A. Newby, Amy E. Moran, Tomasz M. Beer
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Phase 3 studies of immune checkpoint inhibitors have not shown a survival benefit in prostate cancer, but some patients have a profound anticancer response.Patients and Methods: We evaluated the efficacy of the CTLA-4 targeted agent, ipil
Externí odkaz:
https://doaj.org/article/a0ffdd59fa0b4fb68cbe0074fba89eec
Autor:
Yong-Wei Zhang, Rochelle Nasto, Sandra Jablonski, Ilya Serebriiskii, Rishi Surana, Joseph Murray, Michael Johnson, Rebecca Riggins, Robert Clarke, Erica Golemis, Louis Weiner
Publikováno v:
Bio-Protocol, Vol 7, Iss 15 (2017)
RNAi screening technology has revealed unknown determinants of various biological signaling pathways in biomedical studies. This protocol provided detailed information about how to use RNAi screening to identify proliferation determinants in breast t
Externí odkaz:
https://doaj.org/article/6cba6d77142e44609cfe052a4fc8e1cd
Autor:
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, David S. Hong, Timothy A. Yap, Jordi Rodon, Aung Naing, Robert A. Wolff, Brandon G. Smaglo, Funda Meric Bernstam, Vivek Subbiah, Shubham Pant
Publikováno v:
Journal of Gastrointestinal Cancer.
Gene list used to construct IL-4 focused siRNA library.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d67a56cc95b3d9463da98214390182
https://doi.org/10.1158/2326-6066.22536137
https://doi.org/10.1158/2326-6066.22536137
Related Article from Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eda3adff23f0003d65dcc5c2cdc91071
https://doi.org/10.1158/1940-6207.22525332.v1
https://doi.org/10.1158/1940-6207.22525332.v1
Tumor-targeted antibody therapy has had a major impact on reducing morbidity and mortality in a wide range of cancers. Antibodies mediate their antitumor activity in part by activating immune effector cells; however, the tumor microenvironment (TME)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058c30f11c0fd2baa79d724c77313e8d
https://doi.org/10.1158/2326-6066.c.6548054
https://doi.org/10.1158/2326-6066.c.6548054
This perspective on the report by Beatty et al. in this issue of the journal (beginning on page 438) discusses the prevention of cancer through vaccination strategies that target antigens associated with tumor promotion and progression. Such approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa5c9f1038989c6870acba046d645ad
https://doi.org/10.1158/1940-6207.c.6544689.v1
https://doi.org/10.1158/1940-6207.c.6544689.v1
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d116ad51f94627e23afa55197ac74be
https://doi.org/10.1158/2326-6066.22536134.v1
https://doi.org/10.1158/2326-6066.22536134.v1
IL-4 neutralization alters the composition of the tumor microenvironment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5e81d6ccd1abe509a4916ac2d32fa6
https://doi.org/10.1158/2326-6066.22536143
https://doi.org/10.1158/2326-6066.22536143
The impact of host-derived IL-4 on expression of soluble mediators in the tumor microenvironment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69fd2bbde155adcea451f5b5459252d5
https://doi.org/10.1158/2326-6066.22536140.v1
https://doi.org/10.1158/2326-6066.22536140.v1